Viatris (VTRS) Total Debt (QoQ) (2020 - 2026)
Powered by 
Analysis
Viatris (VTRS) Total Debt (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.74 Bn | 39.09 Bn | 2.15 Bn |
| 2 | Viatris | 19.12 Bn | 18.23 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.37 Bn | 530.13 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 991.81 Mn | 701.69 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 412.12 Mn | 370.87 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 182.76 Mn | 182.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.92% |
| Mar 31, 2026 | -0.48% |
| Dec 31, 2025 | -0.18% |
| Sep 30, 2025 | -0.23% |
| Jun 30, 2025 | 2.02% |
| Mar 31, 2025 | 0.99% |
| Dec 31, 2024 | -10.81% |
| Sep 30, 2024 | -7.89% |
| Jun 30, 2024 | -4.85% |
| Mar 31, 2024 | -0.89% |
| Dec 31, 2023 | -1.38% |
| Sep 30, 2023 | -1.18% |
| Jun 30, 2023 | -0.95% |
| Mar 31, 2023 | -2.55% |
| Dec 31, 2022 | -3.57% |
| Sep 30, 2022 | -5.92% |
| Jun 30, 2022 | -3.53% |
| Mar 31, 2022 | -4.61% |
| Dec 31, 2021 | -1.64% |
| Sep 30, 2021 | -3.81% |